Literature DB >> 18791839

Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility.

N J Cohen1, J Y Morita, D K Plate, R C Jones, M T Simon, J Nawrocki, A M Siston, S I Gerber.   

Abstract

BACKGROUND: Chronic care facility residents are at risk of severe influenza infection and death. Adamantanes have been used by chronic care facilities for influenza A prophylaxis; however, genotypic resistance has altered prophylaxis recommendations. An outbreak of influenza A (H3N2) in a chronic care facility housing neurologically impaired children and young adults and subsequent control measures are described. PATIENTS AND METHODS: Resident charts were retrospectively reviewed. Isolates were characterized by strain identification and pyrosequencing.
RESULTS: Although 95 (97%) of 98 residents had been immunized against influenza at the start of the influenza season, 16 (84%) of 19 case patients were identified on the first floor. However, following implementation of enhanced infection control practices and adamantane prophylaxis, only 10 (13%) of 79 case patients were identified on the second floor. Subsequent pyrosequencing studies revealed a serine to asparagine mutation at position 31 of the M2 protein.
CONCLUSIONS: Enhanced infection control precautions and adamantane prophylaxis were used to control spread of influenza in a chronic care facility. This outbreak demonstrates the importance of timely and consistent implementation of infection control measures in controlling influenza outbreaks in long term care facilities and raises questions about a possible role for adamantanes in preventing transmission of adamantane-resistant influenza A viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791839     DOI: 10.1007/s15010-008-7295-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Influenza moves to the front of public health concerns.

Authors:  C Ruef
Journal:  Infection       Date:  2009-06       Impact factor: 3.553

2.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

3.  The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies.

Authors:  Muthannan A Ramakrishnan; Zheng Jin Tu; Sushmita Singh; Ashok K Chockalingam; Marie R Gramer; Ping Wang; Sagar M Goyal; My Yang; David A Halvorson; Srinand Sreevatsan
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

4.  The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.

Authors:  Martha I Nelson; Lone Simonsen; Cécile Viboud; Mark A Miller; Edward C Holmes
Journal:  Virology       Date:  2009-04-24       Impact factor: 3.616

5.  Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.

Authors:  Nila J Dharan; Monica Patton; Alicia M Siston; Julie Morita; Enrique Ramirez; Teresa R Wallis; Varough Deyde; Larisa V Gubareva; Alexande I Klimov; Joseph S Bresee; Alicia M Fry
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.